An 11-year-old boy who presentedin acute renal failure with significant increases of uric acid and phosphorus in his serum was discovered to have acute lymphoblastic leukemia. Five years later, he had a second and similar episode of acute renal failure, which was responsive to hemodialysis.
throat, and epistaxis. Chemical tests at admission revealed acute renal failure. Hematological studies showed a hemoglobin concentration of only 67 g/L, and a leukocyte count of 22.4 x i09/L, with 8% neutrophils, 9% band forms, 77%
lymphocytes, 5% monocytes, and 1% eosinophils. The platelet count was 20 x i0fL. Results of bone-marrow examination were consistent with acute lymphoblastic leukemia, but also were suggestive of a tendency toward spontaneous remission.
Renal function was normalized by intravenous
hydrationwith isotonic saline and glucoseand enemas with Fiveyears after the initial diagnosis, the patient presented again in renal failure. Hemoglobin concentration was 58 g/L; the leukocyte count was 8.9 x i09/L with 81% lymphoblasts, 7% neutrophils, 3% band forms, 7% lymphocytes, and 2% monocytes. The platelet count was 9 x iO9fL. Renal function responded favorably to three courses of hemodialysis, and blood products were administered.
Treatment with allopurinol, 900 mg per day in three divided doses, was begun. At his final admission, three months later, he was againinrenalfailure. The hemoglobin concentration was 92 g/L;the leukocytecount was 3.2 x i09/L with 28% neutrophils, 9% band forms,38% lymphocytes, 2% monocytes, 1% eosinophils, and 22% lymphoblasts.
The platelet countwas 23 x i09/L. Platelets and erythrocytes were administered and hydralazine was given for hypertension, but the patient did not respond favorably. Peritoneal dialysis failed to check 
Methods and Materials
In routine analyses the Kodak Ektachem 400 was used. Standard purine compounds were purchased from Sigma Chemical Co., St. Louis, MO. Stones from the patient were dissolved in 0.1 mmolIL NH4OH togivea concentration of 5 gIL,and they and serum samples were directly analyzedby chromatography or electrophoresis. For paper chromatography we used 3MM paper (Whatman Ltd., Maidstone, England), with butanol-acetic acid-water (12/3/5 by vol) as the solvent system. Paper electrophoresis was also performed on Whatman 3MM paper, in borate buffer (40 mmol/L, pH 8.65), at 75 V/cm for 30 mm. After the purines were located by illuminating the sheet with an ultraviolet lamp, we cut out appropriate sections of the paper and eluted the purines by soaking the pieces of paper overnight in 10 mmoIIL HC1 solution. We identified the various compounds by comparison with co-migrating standards and quantifiedthem by ultraviolet spectrophotometry, using published absorptivity values. Monosodium urate, used for standards, was dissolved in water and its concentration determined by ultraviolet spectrometry.
Aliquots of the solution were lyophilized, then mixed with pooled normal serum to give the desired concentrations.
X-ray diffraction studies were carried out as described by DeVries (13). For infrared analysis of calculi, we used a Digilab 15c Fourier-transform infrared spectrophotometer (VF-IR), and standard potassium bromide pellet procedures. Table 1 summarizes the laboratory findings for the patient at each admission to the hospital. At his first admission, prior to diagnosis and treatment, remarkably high valuesforphosphorus and uric acidwere seen, along with increases inserum urea nitrogenand creatinine, hyperkalemia, and hypocalcemia.Laboratorymeasurements during the second admission,after the diagnosishad been made and the treatment program begun, were very similar, although phosphorus measurements were not carried out. At the time ofthe thirdand final hospital admission, three months after the introduction of treatment with allopurinol, values for urea nitrogen, creatinine, and phosphorus (measured on the third day of this admission) were above normal. Uricacid and potassium concentrations were within normal limits, but there was a significant increase in serum xanthine.
Results
Ten to 12 small tan calculi, 2-3 mm in diameter, were removed from the cut surface of the kidneys and lightly blotted with filter paper. The stones tended to crumble easily into a coarse, gravel-like consistency. Paper chromatography of the stones revealed three ultraviolet-absorbing spots, which co-chromatographed with authentic xanthine, oxypurinol, and hypoxanthine.
On paper electrophoresis three ultraviolet-absorbing spots also co-chromatographed with authentic xanthine, oxypurinol, and hypoxanthine. The ultraviolet spectra of the eluted spots were identical with those ofthe authenticcompounds. Quantification ofthe stone composition showed that itcontained 82% xanthine, 15% oxypurinol, and 3% hypoxanthine. Uric acid and allopurinoi were not detected. Infraredspectroscopy of the stones revealed characteristic absorption bands for xanthine,and the x-raydiffraction pattern was consistent with the presenceofxanthine.
The activity ofthe enzyme hypoxanthine-guaninephosphoribosyltransferase (EC 2.4.2.8) was found not to be deficient in the erythrocytes of blood obtained postmortem from the patient.
DiscussIon
This patient presented initially in renal failure with hyperphosphatemia, hyperkalemia, hyperuricemia, and hypocalcemia. The diagnosis of acute lymphoblastic leukemia was made during this hospitalization, and the histological appearance of a spontaneous ongoing remission was noted. The laboratory findings on the first admission (Table 1) reflect massive cytolysis of tumor cells-the acute tumorlysis syndrome (14-20) . In view of the remarkably high values for serum phosphorus and uric acid, it seems likely that some urate nephropathy and nephrocalcinosis had occurred by this time. During the next five years, the patient had several remissions and partial remissions, but his overallresponse to antileukemic therapy was deemed unsatisfactory. His second major admission was again because of renal failure, with an almost identical biochemical picture (Table 1) . Although serum phosphorus was not measured this time, it isreasonable to assume that he was hyperphosphatemic and that there was now further compromise of renal function. His renal function responded favorably to three courses of hemodialysis and he was discharged with allopurinol, now prescribed to be taken daily. This patient was last admitted threemonths later, again in renal failure. Serum uric acid was now normal on admission and serum phosphorus was 4.84 mmol/L on the third hospital day ( Table 1) . Peritoneal dialysis was instituted, but the patient continued to show progressive deterioration with evidenceofcentral nervous system involvement.
The magnitude ofthe hyperuricemia (Table 1) deserves some comment. A wide variety oftechniques have been used fordeterminationof serum uric acid,but, irrespective of methodology,extensivepopulationstudiesgenerallyhave shown valuesrangingfrom 208 to506 p.mo)JL, with a small proportion of patientshaving values >416 .Lmol/L-a concentration thought to represent the maximum solubility of sodium urate in plasma at 37 #{176}C (21). Uric acid concentration's comparable to those seen in this patientare only rarelyfound in the literature (19) and were at first viewed with suspicion. However, we confirmed a uric acidvalue of 4.4 nunol/L during his second hospitalization, a value obtainedwith the DuPont aca ifi. The Kodak Ektachem 400 and DuPont aca ifi uric acid methods are both enzymically based and are reasonably free from false-positive interference (22) . The addition of pooled sera to lyophilized samples of monosodium urate resulted in measured concentrations of uric acid between 3 and 3.36 mmoL'L in the Ektachem 400, confirmed by paper chromatography. The serum remained clear and translucent for about 1 h at room temperature, then opalescence and crystallization of monosodium urate could begin to be seen. Therefore, the values observed in this patient probably represent a supersaturated state (23) . There was no deficiency of activity of the enzyme hype- Acute and accelerated tumor-celllysisand itsadverse effects, particularly on the kidney, have been well studied and described (14-20) . In this patient, allopurinol effectively prevented hyperuricemia, as evidenced by his normal uric acidconcentration while on the drug-although the actual value may have been somewhat higher because xanthine interferes negativelyin the method (22) . However, in allo-
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purinol-treated
patientswith an accelerated cellular turnover,the xanthineconcentration in serum may increaseto extremely high values, and the concentration in urine may exceed its solubility limit (24) . In this patient, serum xanthine was 3.04 mmolJL (mean normal 24, SD 22 pmolJL) on his third admission and the mean value for xanthine in five blood samples,includinga postmortem sample, during this hospitalization was 2.07 (SD 0.84) mmol/L, clearly setting the stageforxanthinuriaand the initiation and (or) progression ofxanthine lithiasis.
During periods of intensivechemotherapy in patients with a large and sensitivetumor-cellload, subclinical damage may be occurring in the kidney.One shouldmonitorand maintain renalfunctionat thesetimes.Similarly, surveillance forinfection isan essential component of the treatmentprogram. Closeattention tothepotential adverse featuresofthe treatment regimen may prevent morbidity and prolonglife in patientswith neoplastic disease.
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